Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus
Reason given: PI decision based on reduced staffing and funds.
Key facts
- Where
- Kansas City, United StatesSee the site
Where in United States
- Children's MercyKansas City, United StatesNo longer taking part
Trial details
- Who runs it
- Children's Mercy Hospital Kansas City
- Trial code
- NCT06018844
- Record updated
- 19 August 2025
- Original description
The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D)Read full original descriptionShow less
The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D)
The main question[s] it aims to answer are:
* Does the intervention increase the amount of text messages between the mHealth software and participants? * Do the text messages from the Nudge software increase moderate to vigorous physical activity (MVPA) in participants? * Does the MVPA encouraged by the Nudge software improve the HbA1c levels of participants?
Participants will:
* Receive text messages from the Nudge software * Report physical activity goals via the text messages to the Nudge software * Wear both an accelerometer and an actigraph for three weeks (spread out across the beginning, 30 days, and 90 days of participation) * Complete surveys at the beginning of participation * Complete daily surveys while wearing the devices * Complete surveys at the end of participation * Record physical activity in study surveys
Inclusion: Participants 12.00-21.99 years old; Participants with a physician confirmed T1D diagnosis; T1D diagnosis was at least 6 months prior to study enrollment; Participants are on an intensive insulin regiment (either with an insulin pump or multiple daily injection); Participants must be using a continuous glucose monitor (CGM); Participants and parents/legally authorized representatives (LARS) of participants less than 18.00 speak/read English.
Exclusion: Participants with evidence of type 2 or monogenic diabetes; Participants with a comorbid chronic condition (e.g., renal disease); Participants with presence of severe psychiatric disorders; Participants with a diagnosis of low vision (vision that cannot be corrected with contact lenses or eyeglasses); Participants with limited mobility that would prevent participant from engaging in daily physical activity, self-assessed by participant.